Podocytes Produce and Secrete Functional Complement C3 and Complement Factor H

被引:24
|
作者
Muehlig, Anne K. [1 ,2 ]
Keir, Lindsay S. [3 ]
Abt, Jana C. [2 ]
Heidelbach, Hannah S. [2 ]
Horton, Rachel [3 ]
Welsh, Gavin I. [3 ]
Meyer-Schwesinger, Catherine [4 ]
Licht, Christoph [5 ]
Coward, Richard J. [3 ]
Fester, Lars [6 ,7 ]
Saleem, Moin A. [3 ]
Oh, Jun [1 ,2 ]
机构
[1] Univ Med Ctr Hamburg, Univ Childrens Res Kinder UKE, Hamburg, Germany
[2] Univ Med Ctr Hamburg, Univ Childrens Hosp, Dept Pediat Nephrol, Hamburg, Germany
[3] Univ Bristol, Bristol Renal & Childrens Renal Unit, Bristol, Avon, England
[4] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Inst Cellular & Integrat Physiol, Hamburg, Germany
[5] Hosp Sick Children, Div Pediat Nephrol, Toronto, ON, Canada
[6] Univ Med Ctr Hamburg Eppendorf, Dept Neuroanat, Hamburg, Germany
[7] Friedrich Alexander Univ Erlangen Nurnberg, Inst Anat & Cell Biol, Erlangen, Germany
来源
FRONTIERS IN IMMUNOLOGY | 2020年 / 11卷
基金
英国医学研究理事会;
关键词
complement secretion; proteinuria; glomerulus; kidney; local regulation; HEMOLYTIC-UREMIC SYNDROME; ACTIVATED PROTEIN-KINASE; C4; GENE-EXPRESSION; CELL-LINE; INTRACELLULAR COMPLEMENT; ALTERNATIVE PATHWAY; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; COMPONENTS; KIDNEY;
D O I
10.3389/fimmu.2020.01833
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Podocytes are an important part of the glomerular filtration barrier and the key player in the development of proteinuria, which is an early feature of complement mediated renal diseases. Complement factors are mainly liver-born and present in circulation. Nevertheless, there is a growing body of evidence for additional sites of complement protein synthesis, including various cell types in the kidney. We hypothesized that podocytes are able to produce complement components and contribute to the local balance of complement activation and regulation. To investigate the relevant balance between inhibiting and activating sides, our studies focused on complement factor H (CFH), an important complement regulator, and on C3, the early key component for complement activation. We characterized human cultured podocytes for the expression and secretion of activating and regulating complement factors, and analyzed the secretion pathway and functional activity. We studied glomerular CFH and C3 expression in puromycin aminonucleoside (PAN) -treated rats, a model for proteinuria, and the physiological mRNA-expression of both factors in murine kidneys. We found, that C3 and CFH were expressed in cultured podocytes and expression levels differed from those in cultivated glomerular endothelial cells. The process of secretion in podocytes was stimulated with interferon gamma and located in the Golgi apparatus. Cultured podocytes could initiate the complement cascade by the splitting of C3, which can be shown by the generation of C3a, a functional C3 split product. C3 contributed to external complement activation. Podocyte-secreted CFH, in conjunction with factor I, was able to split C3b. Podocytes derived from a patient with a CFH mutation displayed impaired cell surface complement regulation. CFH and C3 were synthesized in podocytes of healthy C57Bl/6-mice and were upregulated in podocytes of PAN treated rats. These data show that podocytes produce functionally active complement components, and could therefore influence the local glomerular complement activation and regulation. This modulating effect should therefore be considered in all diseases where glomerular complement activation occurs. Furthermore, our data indicate a potential novel role of podocytes in the innate immune system.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Interpain A, a Cysteine Proteinase from Prevotella intermedia, Inhibits Complement by Degrading Complement Factor C3
    Potempa, Michal
    Potempa, Jan
    Kantyka, Tomasz
    Nguyen, Ky-Anh
    Wawrzonek, Katarzyna
    Manandhar, Surya P.
    Popadiak, Katarzyna
    Riesbeck, Kristian
    Eick, Sigrun
    Blom, Anna M.
    PLOS PATHOGENS, 2009, 5 (02)
  • [32] Complement components C3 and complement factor B promote growth of cutaneous squamous cell carcinoma
    Riihila, P.
    Nissinen, L.
    Farshchian, M.
    Kallajoki, M.
    Kivisaari, A.
    Meri, S.
    Grenman, R.
    Peltonen, S.
    Peltonen, J.
    Pihlajaniemi, T.
    Heljasvaara, R.
    Kahari, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S20 - S20
  • [33] Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H
    Matthew C. Pickering
    H. Terence Cook
    Joanna Warren
    Anne E. Bygrave
    Jill Moss
    Mark J. Walport
    Marina Botto
    Nature Genetics, 2002, 31 : 424 - 428
  • [34] Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H
    Pickering, MC
    Cook, HT
    Warren, J
    Bygrave, AE
    Moss, J
    Walport, MJ
    Botto, M
    NATURE GENETICS, 2002, 31 (04) : 424 - 428
  • [35] Complement component C3 and complement factor B regulate growth of cutaneous squamous cell carcinoma
    Riihila, Pilvi
    Farshchian, Mehdi
    Kallajoki, Markku
    Kivisaari, Atte
    Meri, Seppo
    Grenman, Reidar
    Heljasvaara, Ritva
    Pihlajaniemi, Taina
    Peltonen, Juha
    Peltonen, Sirkku
    Kahari, Veli-Matti
    CANCER RESEARCH, 2015, 75
  • [36] FACTOR H-RELATED PROTEINS MODULATE COMPLEMENT ACTIVATION VIA THE C3 CONVERTASE
    Uzonyi, Barbara
    Matola, Alexandra Tunde
    Bencze, Daniel
    Szakacs, David
    Jozsi, Mihaly
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 137 - 137
  • [37] An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy
    Nichols, Eva-Maria
    Barbour, Thomas D.
    Pappworth, Isabel Y.
    Wong, Edwin K. S.
    Palmer, Jeremy M.
    Sheerin, Neil S.
    Pickering, Matthew C.
    Marchbank, Kevin J.
    KIDNEY INTERNATIONAL, 2015, 88 (06) : 1314 - 1322
  • [38] Relationship of gene polymorphisms for complement components C3 and factor H and kidney allograft function
    Milinkovic, Marija
    Perovic, Vladimir
    Maksimovic, Stefan
    Vukovic, Irena
    Kravljaca, Milica
    Brkovic, Voin
    Milosevic, Iman Assi
    Radovic, Milan
    Lausevic, Mirjana
    BMC NEPHROLOGY, 2025, 26 (01)
  • [40] Engineering of human complement component C3 for catalytic inhibition of complement
    Kölln, J
    Bredehorst, R
    Spillner, E
    IMMUNOLOGY LETTERS, 2005, 98 (01) : 49 - 56